CN101811991B - L-精氨酸硝酸盐的制备方法 - Google Patents
L-精氨酸硝酸盐的制备方法 Download PDFInfo
- Publication number
- CN101811991B CN101811991B CN2010101703720A CN201010170372A CN101811991B CN 101811991 B CN101811991 B CN 101811991B CN 2010101703720 A CN2010101703720 A CN 2010101703720A CN 201010170372 A CN201010170372 A CN 201010170372A CN 101811991 B CN101811991 B CN 101811991B
- Authority
- CN
- China
- Prior art keywords
- arginine
- nitric acid
- mother liquor
- temperature
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AKGJKCZYBKGMIK-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;nitric acid Chemical compound O[N+]([O-])=O.OC(=O)[C@@H](N)CCCNC(N)=N AKGJKCZYBKGMIK-WCCKRBBISA-N 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title abstract description 16
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims abstract description 56
- 229910017604 nitric acid Inorganic materials 0.000 claims abstract description 56
- 239000012452 mother liquor Substances 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 238000000926 separation method Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000011010 flushing procedure Methods 0.000 claims abstract description 13
- 239000008213 purified water Substances 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims description 15
- 238000002425 crystallisation Methods 0.000 claims description 14
- 230000008025 crystallization Effects 0.000 claims description 14
- 238000005352 clarification Methods 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 238000001816 cooling Methods 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 238000004064 recycling Methods 0.000 abstract description 2
- 229930064664 L-arginine Natural products 0.000 abstract 4
- 235000014852 L-arginine Nutrition 0.000 abstract 4
- 239000013078 crystal Substances 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- 239000000047 product Substances 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ZDLDXNCMJBOYJV-YFKPBYRVSA-N L-arginine, methyl ester Chemical class COC(=O)[C@@H](N)CCCN=C(N)N ZDLDXNCMJBOYJV-YFKPBYRVSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101703720A CN101811991B (zh) | 2010-05-12 | 2010-05-12 | L-精氨酸硝酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101703720A CN101811991B (zh) | 2010-05-12 | 2010-05-12 | L-精氨酸硝酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101811991A CN101811991A (zh) | 2010-08-25 |
CN101811991B true CN101811991B (zh) | 2012-11-07 |
Family
ID=42619377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101703720A Active CN101811991B (zh) | 2010-05-12 | 2010-05-12 | L-精氨酸硝酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101811991B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103664705A (zh) * | 2013-12-13 | 2014-03-26 | 天津天成制药有限公司 | 瓜氨酸硝酸盐的合成方法 |
CN103613508A (zh) * | 2013-12-16 | 2014-03-05 | 天津天成制药有限公司 | γ-氨基丁酸硝酸盐的制备方法 |
CN112342253A (zh) * | 2020-11-10 | 2021-02-09 | 湖南天成生化科技有限公司 | 高收率l-精氨酸硝酸盐的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127421A (en) * | 1996-01-31 | 2000-10-03 | The Board Of Trustees Of The University Of Arkansas | In ovo use of L-arginine and salts thereof in the prevention and/or treatment of pulmonary hypertension syndrome in avians |
-
2010
- 2010-05-12 CN CN2010101703720A patent/CN101811991B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127421A (en) * | 1996-01-31 | 2000-10-03 | The Board Of Trustees Of The University Of Arkansas | In ovo use of L-arginine and salts thereof in the prevention and/or treatment of pulmonary hypertension syndrome in avians |
Non-Patent Citations (2)
Title |
---|
吴泳等.碱性氨基酸的制备.《大学化学新体系实验》.科学出版社,1999,231-233. * |
陈来同等.氨基酸类生化产品制备技术.《生物化学产品制备技术》.科学技术文献出版社,2003,146-147. * |
Also Published As
Publication number | Publication date |
---|---|
CN101811991A (zh) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104788345B (zh) | 一种高纯度盐酸二甲双胍的生产方法 | |
CN105601542B (zh) | 一种混酸结晶n‑氨甲酰谷氨酸的方法 | |
CN104561202B (zh) | 一种酶催化合成丙谷二肽的制备方法及工艺系统 | |
CN101811991B (zh) | L-精氨酸硝酸盐的制备方法 | |
CN103167872B (zh) | 用于生产l-肉碱酒石酸盐的方法 | |
CN101125809B (zh) | 一种无溶剂、免加热合成二甲酸钾的方法 | |
CN110776420A (zh) | 一种卡巴匹林钙的合成工艺 | |
WO2012071766A1 (zh) | 从发酵液中直接结晶制备L-精氨酸-α-酮戊二酸盐的方法 | |
CN102351790A (zh) | 7-溴-6-氯-4(3h)-喹诺酮的合成方法 | |
CN107445869A (zh) | 一种盐酸二甲双胍的合成方法 | |
CN101844991B (zh) | L-亮氨酸硝酸盐的制备方法 | |
CN101817758B (zh) | L-缬氨酸硝酸盐的制备方法 | |
CN111517972A (zh) | 一种环保甜菜碱的制备方法 | |
CN102838512A (zh) | 肌酸硝酸盐的制备方法 | |
CN102584636A (zh) | 肌酸的合成方法 | |
CN112778150A (zh) | 一种γ-氨基丁酸的新晶型及其制备方法 | |
CN102850241A (zh) | 胍基乙酸硝酸盐的制备方法 | |
CN102850232A (zh) | L-丝氨酸硝酸盐的制备方法 | |
CN107805222B (zh) | 一种尿囊素合成母液的综合利用方法 | |
CN102850242A (zh) | 胍基丙酸硝酸盐的制备方法 | |
CN107043343A (zh) | 一种l‑焦谷氨酸的制备方法 | |
CN101817757B (zh) | L-异亮氨酸硝酸盐的制备方法 | |
CN109836347A (zh) | 一种l-异亮氨酸结晶制备工艺 | |
CN103664705A (zh) | 瓜氨酸硝酸盐的合成方法 | |
CN101817762B (zh) | L-谷氨酰胺硝酸盐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing L-arginine nitrate Effective date of registration: 20130320 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013120000001 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20131028 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013120000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing L-arginine nitrate Effective date of registration: 20131108 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013990000831 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PP01 | Preservation of patent right |
Effective date of registration: 20140526 Granted publication date: 20121107 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130606 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013610000002 Date of cancellation: 20130606 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013110000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing L-arginine nitrate Effective date of registration: 20130606 Granted publication date: 20121107 Pledgee: Export Import Bank of China Pledgor: Tianjin Tiancheng Pharmaceutical Co., Ltd. Registration number: 2013110000001 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20150526 Granted publication date: 20121107 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20150526 Granted publication date: 20121107 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20151126 Granted publication date: 20121107 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160414 Granted publication date: 20121107 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20161014 Granted publication date: 20121107 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20161102 Granted publication date: 20121107 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170502 Granted publication date: 20121107 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20170519 Granted publication date: 20121107 |